Roger Adsett
Chief Operating Officer presso INSMED INCORPORATED
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Roger Adsett is currently an Independent Director at Landos Biopharma, Inc. since 2022.
He is also currently serving as the Chief Operating Officer at Insmed, Inc. since 2016.
Previously, he worked at AstraZeneca PLC as the Director of Marketing & Brand from 1994 to 2005.
He also held the position of Marketing Director at AstraZeneca R & D Lund and Nexium, Inc. From 2005 to 2016, he worked at Shire Plc as the SVP and Head of Gastrointestinal & Internal Medicine.
Mr. Adsett completed his undergraduate degree at Bucknell University and holds an MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INSMED INCORPORATED
0.10% | 12/01/2024 | 148 559 ( 0.10% ) | 4 M $ | 31/03/2024 |
LANDOS BIOPHARMA, INC.
-.--% | 23/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Roger Adsett
| Società | Posizione | Inizio |
|---|---|---|
| INSMED INCORPORATED | Chief Operating Officer | 14/11/2019 |
| LANDOS BIOPHARMA, INC. | Director/Board Member | 08/03/2022 |
Precedenti posizioni note di Roger Adsett
| Società | Posizione | Fine |
|---|---|---|
| SHIRE | Corporate Officer/Principal | 01/09/2016 |
| ASTRAZENECA PLC | Sales & Marketing | 01/10/2005 |
| Nexium, Inc. | Sales & Marketing | - |
| AstraZeneca R & D Lund | Sales & Marketing | - |
Formazione di Roger Adsett
| Bucknell University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| INSMED INCORPORATED | Health Technology |
| LANDOS BIOPHARMA, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Nexium, Inc. | Finance |
| AstraZeneca R & D Lund |
- Borsa valori
- Insiders
- Roger Adsett
